Parkman Healthcare Partners LLC增加了阿波罗内外科公司（纳斯达克股票代码：APEN）的股票状况

Parkman Healthcare Partners LLC raised its holdings in Apollo Endosurgery, Inc. (NASDAQ:APEN – Get Rating) by 1.2% in the third quarter, HoldingsChannel reports. The institutional investor owned 657,690 shares of the biotechnology company's stock after acquiring an additional 7,690 shares during the quarter. Parkman Healthcare Partners LLC's holdings in Apollo Endosurgery were worth $3,624,000 as of its most recent SEC filing.

Several other institutional investors have also recently modified their holdings of the company. Worth Venture Partners LLC raised its stake in shares of Apollo Endosurgery by 1.7% in the third quarter. Worth Venture Partners LLC now owns 126,535 shares of the biotechnology company's stock worth $697,000 after purchasing an additional 2,135 shares during the last quarter. Lazard Asset Management LLC raised its stake in shares of Apollo Endosurgery by 77.5% in the second quarter. Lazard Asset Management LLC now owns 10,904 shares of the biotechnology company's stock worth $39,000 after purchasing an additional 4,762 shares during the last quarter. Cambridge Investment Research Advisors Inc. purchased a new position in shares of Apollo Endosurgery in the first quarter worth about $67,000. Essex Investment Management Co. LLC raised its stake in shares of Apollo Endosurgery by 2.9% in the third quarter. Essex Investment Management Co. LLC now owns 400,573 shares of the biotechnology company's stock worth $2,207,000 after purchasing an additional 11,159 shares during the last quarter. Finally, Jump Financial LLC purchased a new position in shares of Apollo Endosurgery in the third quarter worth about $62,000. 76.01% of the stock is currently owned by hedge funds and other institutional investors.

Apollo Endosurgery Price Performance

Apollo Endosurgery stock traded down $0.01 during midday trading on Monday, hitting $9.94. 432,810 shares of the company were exchanged, compared to its average volume of 1,637,189. Apollo Endosurgery, Inc. has a fifty-two week low of $3.49 and a fifty-two week high of $10.30. The business has a fifty day simple moving average of $9.91 and a two-hundred day simple moving average of $7.83. The company has a quick ratio of 4.98, a current ratio of 6.00 and a debt-to-equity ratio of 1.26.

Analyst Ratings Changes

Several research analysts have recently issued reports on the company. Cowen cut Apollo Endosurgery from an "outperform" rating to a "market perform" rating and reduced their price objective for the stock from $13.00 to $10.00 in a research note on Monday, January 23rd. Lake Street Capital lowered Apollo Endosurgery from a "buy" rating to a "hold" rating and dropped their target price for the stock from $14.00 to $10.00 in a report on Wednesday, November 30th. Finally, Stifel Nicolaus lowered Apollo Endosurgery from a "buy" rating to a "hold" rating and set a $10.00 target price on the stock. in a report on Tuesday, January 3rd.

Apollo Endosurgery Profile

(Get Rating)

Apollo Endosurgery, Inc is a medical technology company, which focuses on the design, development, and commercialization of medical devices to advance gastrointestinal therapeutic endoscopy. It offers Endoscopy, Surgical and Other products. The firm's endoscopy product portfolio consists of the OverStitch Endoscopic Suturing System, the OverStitch Sx Endoscopic Suturing System, and the Orbera Intragastric Balloon System.

See Also

• Get a free copy of the StockNews.com research report on Apollo Endosurgery (APEN)
• Go Where the Money Is. Here's 3 Top Bank Dividend Stocks to Buy
• Another Catalyst For Mullen Automotive Stock
• Solar Tech-Services; Nextracker Should Be On Your Radar
• Is American Lithium a Safe Bet as Demand for Lithium Soars
• Highwoods Properties, High-quality Real Estate for a Discount

Want to see what other hedge funds are holding APEN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Apollo Endosurgery, Inc. (NASDAQ:APEN – Get Rating).

Receive News & Ratings for Apollo Endosurgery Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apollo Endosurgery and related companies with MarketBeat.com's FREE daily email newsletter.